Literature DB >> 709562

Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.

S Ostrow, D Hahn, P H Wiernik, R D Richards.   

Abstract

Two cases of apparent ophthalmologic toxicity which occurred during treatment with cis-dichlorodiammineplatinum(II) (DDP) are described. In the first case, a patient with testicular carcinoma developed papilledema after three courses of DDP and adriamycin therapy. In the second case, a patient with breast cancer developed retrobulbar neuritis after three courses of DDP therapy. The differential diagnosis and possible explanation for these toxic effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 709562

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  11 in total

1.  Drug-induced peripheral neuropathies.

Authors:  A M Arnold; C J Williams
Journal:  Br Med J       Date:  1979-04-07

2.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

3.  Cisplatin-induced gastric paresis.

Authors:  S C Cohen; J E Mollman
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 5.  [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].

Authors:  R Osieka; C G Schmidt
Journal:  Klin Wochenschr       Date:  1979-12-03

6.  Chemotherapy of eyelid and peritorbital tumors.

Authors:  M N Luxenberg; T H Guthrie
Journal:  Trans Am Ophthalmol Soc       Date:  1985

7.  Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II.

Authors:  R Becher; P Schütt; R Osieka; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

8.  Cis-platinum chemotherapy for ocular basal cell carcinoma.

Authors:  M Morley; P T Finger; M Perlin; L R Weiselberg; D S DeBlasio
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

9.  Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case.

Authors:  V Scaioli; A Caraceni; C Martini; E Palazzini; E Tarenzi; F Fulfaro; E Munzone
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Carboplatin-Induced Bilateral Papilledema: A Case Report.

Authors:  N Fischer; J Stuermer; B Rodic; M Pless
Journal:  Case Rep Oncol       Date:  2009-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.